. Author manuscript; available in PMC: 2012 Apr 4.

Published in final edited form as: J Infect Dis. 2003 Jan 29;187(4):569–575. doi: 10.1086/367995

Table 1.

Distribution of CCR5 genotypes among human immunodeficiency virus type 1 (HIV-1)–uninfected subjects and HIV-1–infected subjects, in the Women's Interagency Human Immunodeficiency Virus Study (WIHS).

	CCR5 genotype

	Wild type		Heterozygote		Δ32 allele frequency

Characteristic	HIV-1 uninfected	HIV-1 infected	HIV-1 uninfected	HIV-1 infected	HIV-1 uninfected	HIV-1 infected
WIHS subjects	513	1940	45	107	0.040	0.026
Race/ethnicity
Black	283	1096	13	39	0.022	0.017
Latina	148	461	9	22	0.029	0.023
White	66	331	20	43	0.116	0.057
Other	16	52	3	3	0.079	0.027
Transmission risk^a
Injection drug use	137	656	16	34	0.052	0.025
Heterosexual	132	797	12	50	0.042	0.030
Transfusion	14	75	1	4	0.033	0.025
Not identified	226	393	15	19	0.031	0.023
WIHS site
Bronx-Manhattan	108	395	6	23	0.026	0.028
Brooklyn	81	300	5	11	0.029	0.018
Chicago	55	256	3	15	0.026	0.028
Washington, DC	86	278	15	14	0.074	0.024
Los Angeles	102	395	9	25	0.041	0.030
San Francisco	81	316	7	19	0.040	0.028

NOTE. Data are no. (%) of participants, unless otherwise indicated.

There were 24 women with missing data on transmission risk status.